RIVN
Rivian Automotive, Inc.
RIVN has a slight edge over SON overall, supported by stronger fundamentals and stronger modeled upside.
SON
Sonoco Products Company
SON has lower modeled downside risk, despite its lower overall score.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SON Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Weak |
SON's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
SON PE Valuation
SON has no meaningful PE right now: it lost money over the past year.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RIVN has the edge over SON on the outlook, with more favorable earnings and revenue expectations.
SON Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect SON's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN has the edge over SON on earnings, with more consistent year-over-year improvement.
SON Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.61 | — |
| Q3 2026 | -$2.30 | -137% |
| Q2 2026 | $6.29 | +13% |
| Q1 2026 | $10.20 | +562% |
| Q4 2025 | $10.07 | +510% |
| Q3 2025 | $6.30 | +116% |
| Q2 2025 | $5.58 | +50% |
| Q1 2025 | $1.54 | -61% |
| Q4 2024 | $1.65 | -66% |
SON has swung to a loss: it lost $2.30 per share over the past year, after a profit the year before.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over SON on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
SON Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | -4.2% |
| Q2 2026 | $1.9B | -1.3% |
| Q1 2026 | $1.7B | -1.9% |
| Q4 2025 | $1.8B | +30% |
| Q3 2025 | $2.1B | +27% |
| Q2 2025 | $1.9B | +18% |
| Q1 2025 | $1.7B | +4.4% |
| Q4 2024 | $1.4B | -17% |
SON's revenue has held roughly level: $2B last quarter, down 4.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -31% | -40 points |
| Q2 2026 | 10% | +1 points |
| Q1 2026 | 7.6% | +0.2 points |
| Q4 2025 | 29% | +33 points |
| Q3 2025 | 9.2% | +1.5 points |
| Q2 2025 | 9.2% | +0.5 points |
| Q1 2025 | 7.4% | +0.5 points |
| Q4 2024 | -4% | -12 points |
SON has the edge over RIVN on profitability, with a higher operating margin.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
SON Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $221.9M | -1.6% |
| Q2 2026 | $236.9M | +140% |
| Q1 2026 | -$430M | -$129.3M |
| Q4 2025 | $322.3M | +17% |
| Q3 2025 | $225.6M | +220% |
| Q2 2025 | $98.6M | +516% |
| Q1 2025 | -$300.8M | -477% |
| Q4 2024 | $274.3M | +74% |
SON has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
SON Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -279K shares |
| 1 year | -0.1% | -146K shares |
| 3 years | +0.6% | +590K shares |
| 5 years | +0.1% | +77K shares |
| Available history | -1.7% | -1.7M shares |
SON has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $181,000 |
| Q2 2026 | $57,000 |
| Q1 2026 | $7M |
| Q4 2025 | $350,000 |
| Q3 2025 | $4,000 |
| Q2 2025 | $3,000 |
| Q1 2025 | $10.6M |
| Q4 2024 | $74,000 |
SON spent $8M buying back its own shares over the past year, down 29% from the year before.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SON Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.6x | High |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 5.3x | High |
| Q2 2025 | 6.2x | High |
| Q1 2025 | 9.3x | High |
| Q4 2024 | 9.4x | High |
SON's net debt is about 5.6 years of its operating earnings (EBITDA), up from 5.3 years a year ago.
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
SON Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.6 | Neutral |
| Stochastic | 22.6 | Neutral |
SON's weekly RSI is 44 (neutral) and its Stochastic is 23 (neutral).
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
SON PE vs Consumer Cyclical Sector
| Metric | SON | Sector median | Relative |
|---|---|---|---|
| PE | 7.9x | 18x | 56% below |
| PE % | 15 | 47 | 32 pts below |
SON has no meaningful PE right now: it lost money over the past year.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
SON Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $49.5 | 1.6% below |
| 20 week MA | $53.1 | 8.2% below |
| 50 week MA | $51.3 | 5% below |
| 100 week MA | $48.3 | 0.9% above |
| 200 week MA | $52.3 | 6.8% below |
SON has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.
SON Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $61.3 | $59.4 | -3.1% |
| 2021 | $59.4 | $55.5 | -6.6% |
| 2022 | $55.5 | $60.4 | +8.9% |
| 2023 | $60.4 | $55.9 | -7.5% |
| 2024 | $55.9 | $48.9 | -12% |
| 2025 | $48.9 | $43.5 | -11% |
| 2026 YTD | $43.5 | $48.7 | +12% |
SON has the edge over RIVN on returns for 2026, with the stronger performance.